Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Chen, E. Murphy, H. Yee (2013)
eReferral--a new model for integrated care.The New England journal of medicine, 368 26
J. Guy, H. Yee (2009)
Health disparities in liver disease: Time to take notice and take actionHepatology, 50
HS Chahal, EA Marseille, JA Tice
Cost-effectiveness of early treatment of hepatitis C virus genotype 1 by stage of liver fibrosis in a US treatment-naive population [published online November 23, 2015].
Tracey Simon, R. Chung (2015)
The new hepatitis C virus bottleneck: Can delaying therapy be justified?Hepatology, 62
Aasld Panel (2015)
Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virusHepatology, 62
M. Surjadi, Cara Torruellas, C. Ayala, H. Yee, M. Khalili (2010)
Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable PopulationsDigestive Diseases and Sciences, 56
Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis Original Investigation Research 56. Cardoso AC, Moucari R, Figueiredo-Mendes C, 61. Ng V, Saab S. Effects of a sustained virologic 66. Brennan TA, Lotvin A, Shrank W. Analysis of et al. Impact of peginterferon and ribavirin therapy response on outcomes of patients with chronic “real world” Sovaldi (sofosbuvir) use and on hepatocellular carcinoma: incidence and survival hepatitis C. Clin Gastroenterol Hepatol. 2011;9(11): discontinuation rates. CVS Health. https://www in hepatitis C patients with advanced fibrosis. 923-930. .cvshealth.com/sites/default/files/styles J Hepatol. 2010;52(5):652-657. /SovaldiUseAndDiscontinuation_ResearchArticle 62. Reuters. Anthem selects Gilead as primary _PDF.pdf. September 2014. Accessed October 1, 2014. 57. McCombs J, Matsuda T, Tonnu-Mihara I, et al. supplier of hepatitis C drugs. http://www.reuters The risk of long-term morbidity and mortality in .com/article/2015/01/08/anthem-gilead-hepatitis 67. Belperio PS. Treating hepatitis C in Veterans patients with chronic hepatitis C: results from an -idUSL1N0UN2IV20150108. Published January 8, Affairs (VA): early experience with sofosbuvir-based analysis of data from a Department of Veterans 2105. Accessed April 15, 2015. regimens. Palo Alto, CA: VA Office of Public Affairs clinical registry. JAMA Intern Med. 2014;174 Health/Population Health and VA Pharmacy Benefits 63. Express scripts and AbbVie make hepatitis C (2):204-212.
JAMA Internal Medicine – American Medical Association
Published: Jan 1, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.